Natalya Raspopova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Natalya Raspopova has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Saida Yeshimbetova
NEI «Kazakh-Russian Medical University
4 shared publications - Kuanysh Altynbekov
Астана қаласы әкімдігінің «Қалалық психикалық денсаулық орталығы» ШЖҚ МКК, Астана, Қазақстан
2 shared publications - Maria Sh Dzhamantayeva
Kazakh-Russian Medical University
2 shared publications - Oksana Kokshinova
«Kazakh-Russian Medical University», Almaty, Kazakhstan
2 shared publications - D.Y. Struchkova
Department of Psychiatry and Narcology NEI “Kazakhstan-Russian Medical University” Almaty, Republic of Kazakhstan
1 shared publication - E.Z. Serikova
Department of Psychiatry and Narcology NEI “Kazakhstan-Russian Medical University” Almaty, Republic of Kazakhstan
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Non-state educational institution "Kazakh-Russian Medical University" in Actual Problems of Theoretical and Clinical Medicine
- No. 3
HISTORICAL AND MODERN CRITERIA FOR THE DIAGNOSIS OF AUTISM (ANALYTICAL LITERATURE REVIEW)
Introduction. The increasing recorded prevalence of autism spectrum disorders among children highlights the importance of early identification and accurate diagnosis. Examining the evolution of autism concepts helps trace the development of clinical criteria and approaches to care. Objective. To analyze the development of autism concepts and diagnostic criteria for autism spectrum disorders, considering historical changes in classification and current approaches to diagnosis in children. Materials and methods. An analytical literature review was conducted using ScienceDirect, MEDLINE/PubMed, CyberLeninka, eLibrary, and Google Scholar. Publications on the history of autism research, clinical manifestations, and diagnosis were examined alongside World Health Organization documents and epidemiological data from the US Autism and Developmental Disabilities Monitoring Network. Diagnostic approaches across editions of the International Classification of Diseases and the Diagnostic and Statistical Manual of Mental Disorders were compared. Results. The reviewed sources describe the transition from early clinical accounts of autism to its recognition as an independent diagnostic category and the subsequent development of a spectrum approach. In DSM-5 and DSM-5-TR, diagnosis requires persistent deficits in social communication and interaction combined with restricted, repetitive patterns of behavior and fulfillment of additional diagnostic requirements. ICD-11 uses specifiers for intellectual development and functional language. Clinical heterogeneity and co-occurring conditions complicate differential diagnosis. Interpretation of increasing recorded prevalence requires consideration of differences in identification methods and study populations. Conclusions. Current diagnosis of autism spectrum disorders requires assessment of all diagnostic criteria, developmental history, intellectual and language functioning, and co-occurring conditions. The spectrum approach helps describe clinical heterogeneity while retaining the need for differential diagnosis. Early identification and individualized interdisciplinary care are important for children’s adaptation and social functioning.
- 1 January 2026
- Published by Non-state educational institution "Kazakh-Russian Medical University" in Actual Problems of Theoretical and Clinical Medicine
- No. 3
Open AccessHISTORICAL AND MODERN CRITERIA FOR THE DIAGNOSIS OF AUTISM (ANALYTICAL LITERATURE REVIEW)
Introduction. The increasing recorded prevalence of autism spectrum disorders among children highlights the importance of early identification and accurate diagnosis. Examining the evolution of autism concepts helps trace the development of clinical criteria and approaches to care. Objective. To analyze the development of autism concepts and diagnostic criteria for autism spectrum disorders, considering historical changes in classification and current approaches to diagnosis in children. Materials and methods. An analytical literature review was conducted using ScienceDirect, MEDLINE/PubMed, CyberLeninka, eLibrary, and Google Scholar. Publications on the history of autism research, clinical manifestations, and diagnosis were examined alongside World Health Organization documents and epidemiological data from the US Autism and Developmental Disabilities Monitoring Network. Diagnostic approaches across editions of the International Classification of Diseases and the Diagnostic and Statistical Manual of Mental Disorders were compared. Results. The reviewed sources describe the transition from early clinical accounts of autism to its recognition as an independent diagnostic category and the subsequent development of a spectrum approach. In DSM-5 and DSM-5-TR, diagnosis requires persistent deficits in social communication and interaction combined with restricted, repetitive patterns of behavior and fulfillment of additional diagnostic requirements. ICD-11 uses specifiers for intellectual development and functional language. Clinical heterogeneity and co-occurring conditions complicate differential diagnosis. Interpretation of increasing recorded prevalence requires consideration of differences in identification methods and study populations. Conclusions. Current diagnosis of autism spectrum disorders requires assessment of all diagnostic criteria, developmental history, intellectual and language functioning, and co-occurring conditions. The spectrum approach helps describe clinical heterogeneity while retaining the need for differential diagnosis. Early identification and individualized interdisciplinary care are important for children’s adaptation and social functioning.
- 24 September 2024
- Published by Asfendiyarov Kazakh National Medical University in Vestnik
- No. 3(70),p. 39-49
EXPERIENCE OF TELEMEDICAL CONSULTING IN CLINICAL PSYCHIATRY OF THE REPUBLIC OF KAZAKHSTAN
Introduction. Telemedicine is a type of use of telecommunication technologies to provide remote medical advice. The most intensive development of teleconsultations began during the COVID-19 pandemic, when face-to-face consultations became difficult. Previously, the experience of teleconsultation in psychiatric practice has not been analyzed on the territory of the Republic of Kazakhstan. Aims. For the first time, a study of the experience of telemedicine consultation was conducted at the “Republican Scientific and Practical Center for Mental Health” of the Ministry of Health of the Republic of Kazakhstan (RNPCPZ MOH RK), to improve the treatment and diagnostic service of a psychiatric profile. Materials and Methods. 53 protocols of telemedicine calls from 13 regions of the country were studied. The socio-demographic and clinical indicators of patients who underwent telemedicine consultation were studied. Absolute numbers and percentages are given, average values and deviations are calculated using the Student's method. Results. It was found that the number of online consultations increased annually and the vast majority of which were initial requests (n=48 - 90.6%). The age range of consulted patients ranged from 3 to 74 years, with a mean age of 26±3.6. The vast majority of those consulted were adolescents and young adults aged from 13 to 28 years with an average age of 19±3.4. The range of established diagnoses was quite wide and corresponded to mental disorders from the neurotic to the endogenous level. Along with this, the most common reason for contact was the question of verification of diagnosis and correction of therapy (n=39 - 73.6%). Conclusion. A growing need for the development of remote consultation and the interest of regional doctors in telemedicine technologies have been identified. Введение. Телемедицина – это вид использования телекоммуникационных технологий для оказания дистанционной консультативной медицинской помощи. (В Казахстане?) интенсивное развитие началось в период пандемии COVID-19, когда очное консультирование стало затруднительным. Раннее на территории Республики Казахстан не был проанализирован опыт телеконсультирования в психиатрической практике. Цель исследования. Впервые проведено изучение опыта телемедицинского консультирования в «Республиканском научно-практическом центре психического здоровья» Министерства Здравоохранения Республики Казахстан (РНПЦПЗ МЗ РК), для совершенствования лечебно-диагностической службы психиатрического профиля. Материалы и методы. Исследовано 53 протокола телемедицинских обращений из 13 областей страны. Изучению подвергнуты клинические и социально-демографические показатели пациентов, прошедших телемедицинское консультирование. Статистический анализ проведен сплошным методом, рассчитаны экстенсивные и интенсивные показатели, средние величины по методике Стьюдента Результаты. Установлено, что количество онлайн консультаций ежегодно возрастало и подавляющее большинство которых составили первичные обращения (n=48 - 90,6%). Возрастной диапазон консультированных пациентов варьировал от 3-х до 74 лет, со средним возрастом 26±3,6. Превалирующее большинство консультированных лиц соответствовали подростковому и молодому возрасту от 13 до 28 лет со средним возрастом 19±3,4. Диапазон установленных диагнозов был достаточно широк и соответствовал расстройствам психической сферы от невротического до эндогенного уровня. Наряду с этим наиболее частым поводом для обращения являлся вопрос о верификации диагноза и коррекции терапии (n=39 - 73,6%). Выводы. Выявлена нарастающая потребность в развитии дистанционного консультирования и заинтересованность региональных врачей к телемедицинским технологиям. Кіріспе. Телемедицина – бұл телекоммуникациялық технологияларды пайдалану арқылы қашықтықтан медициналық кеңес беру түрі. Қазақстанда телемедицина пандемия кезіндегі COVID-19 кезінде қарқынды дамыды, себебі бетпе-бет кеңес беру қиындық туғызды. Республика аумағында психиатриялық практикада телекеңес беру тәжірибесі бұрын-соңды зерттелмеген. Зерттеу мақсаты. Қазақстан...
- 24 September 2024
- Published by Asfendiyarov Kazakh National Medical University in Vestnik
- No. 3(70),p. 39-49
EXPERIENCE OF TELEMEDICAL CONSULTING IN CLINICAL PSYCHIATRY OF THE REPUBLIC OF KAZAKHSTAN
Introduction. Telemedicine is a type of use of telecommunication technologies to provide remote medical advice. The most intensive development of teleconsultations began during the COVID-19 pandemic, when face-to-face consultations became difficult. Previously, the experience of teleconsultation in psychiatric practice has not been analyzed on the territory of the Republic of Kazakhstan. Aims. For the first time, a study of the experience of telemedicine consultation was conducted at the “Republican Scientific and Practical Center for Mental Health” of the Ministry of Health of the Republic of Kazakhstan (RNPCPZ MOH RK), to improve the treatment and diagnostic service of a psychiatric profile. Materials and Methods. 53 protocols of telemedicine calls from 13 regions of the country were studied. The socio-demographic and clinical indicators of patients who underwent telemedicine consultation were studied. Absolute numbers and percentages are given, average values and deviations are calculated using the Student's method. Results. It was found that the number of online consultations increased annually and the vast majority of which were initial requests (n=48 - 90.6%). The age range of consulted patients ranged from 3 to 74 years, with a mean age of 26±3.6. The vast majority of those consulted were adolescents and young adults aged from 13 to 28 years with an average age of 19±3.4. The range of established diagnoses was quite wide and corresponded to mental disorders from the neurotic to the endogenous level. Along with this, the most common reason for contact was the question of verification of diagnosis and correction of therapy (n=39 - 73.6%). Conclusion. A growing need for the development of remote consultation and the interest of regional doctors in telemedicine technologies have been identified. Введение. Телемедицина – это вид использования телекоммуникационных технологий для оказания дистанционной консультативной медицинской помощи. (В Казахстане?) интенсивное развитие началось в период пандемии COVID-19, когда очное консультирование стало затруднительным. Раннее на территории Республики Казахстан не был проанализирован опыт телеконсультирования в психиатрической практике. Цель исследования. Впервые проведено изучение опыта телемедицинского консультирования в «Республиканском научно-практическом центре психического здоровья» Министерства Здравоохранения Республики Казахстан (РНПЦПЗ МЗ РК), для совершенствования лечебно-диагностической службы психиатрического профиля. Материалы и методы. Исследовано 53 протокола телемедицинских обращений из 13 областей страны. Изучению подвергнуты клинические и социально-демографические показатели пациентов, прошедших телемедицинское консультирование. Статистический анализ проведен сплошным методом, рассчитаны экстенсивные и интенсивные показатели, средние величины по методике Стьюдента Результаты. Установлено, что количество онлайн консультаций ежегодно возрастало и подавляющее большинство которых составили первичные обращения (n=48 - 90,6%). Возрастной диапазон консультированных пациентов варьировал от 3-х до 74 лет, со средним возрастом 26±3,6. Превалирующее большинство консультированных лиц соответствовали подростковому и молодому возрасту от 13 до 28 лет со средним возрастом 19±3,4. Диапазон установленных диагнозов был достаточно широк и соответствовал расстройствам психической сферы от невротического до эндогенного уровня. Наряду с этим наиболее частым поводом для обращения являлся вопрос о верификации диагноза и коррекции терапии (n=39 - 73,6%). Выводы. Выявлена нарастающая потребность в развитии дистанционного консультирования и заинтересованность региональных врачей к телемедицинским технологиям. Кіріспе. Телемедицина – бұл телекоммуникациялық технологияларды пайдалану арқылы қашықтықтан медициналық кеңес беру түрі. Қазақстанда телемедицина пандемия кезіндегі COVID-19 кезінде қарқынды дамыды, себебі бетпе-бет кеңес беру қиындық туғызды. Республика аумағында психиатриялық практикада телекеңес беру тәжірибесі бұрын-соңды зерттелмеген. Зерттеу мақсаты. Қазақстан...
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (4) , 69-74
Pathogenetic basis of modern approaches to the therapy of sleep disorders in the clinic of depression
Epidemiological studies indicate that about 35% of the world’s population periodically suffer from insomnia. Many authors in their studies note sleep disturbances in the clinic of both somatic and mental disorders, often considering sleep disturbances as one of the predictors of these diseases. In psychiatric practice, sleep disorders are most often described in the clinic of depression, which is determined by the general pathophysiological mechanisms of their development due to disruption of the activity of the main neurotransmitter systems of the brain. The results of clinical studies show that the drug of choice in the treatment of sleep disorders in the depression clinic is the antidepressant Mirtazapine, which has a unique profile of pharmacological activity. According to international recommendations, Mirtazapine is a first-line drug in the treatment of anxiety and depressive disorders with sleep disorders and sexual dysfunction caused by taking other antidepressants.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (4) , 69-74
Pathogenetic basis of modern approaches to the therapy of sleep disorders in the clinic of depression
Epidemiological studies indicate that about 35% of the world’s population periodically suffer from insomnia. Many authors in their studies note sleep disturbances in the clinic of both somatic and mental disorders, often considering sleep disturbances as one of the predictors of these diseases. In psychiatric practice, sleep disorders are most often described in the clinic of depression, which is determined by the general pathophysiological mechanisms of their development due to disruption of the activity of the main neurotransmitter systems of the brain. The results of clinical studies show that the drug of choice in the treatment of sleep disorders in the depression clinic is the antidepressant Mirtazapine, which has a unique profile of pharmacological activity. According to international recommendations, Mirtazapine is a first-line drug in the treatment of anxiety and depressive disorders with sleep disorders and sexual dysfunction caused by taking other antidepressants.
- 3 July 2023
- Published by Index Copernicus in Acta Neuropsychologica
- Vol. 21 (3) , 207-221
PSYCHOGENIC FACTORS AS A CAUSE OF DEPRESSIVE DISORDERS IN THE ELDERLY
- 3 July 2023
- Published by Index Copernicus in Acta Neuropsychologica
- Vol. 21 (3) , 207-221
PSYCHOGENIC FACTORS AS A CAUSE OF DEPRESSIVE DISORDERS IN THE ELDERLY
- Open Access
- 13 December 2021
- Published by Healthcare of Kazakhstan in International Professional Journal "Medicine"
- Vol. 5-6 (215-216) , 53-62
Modern approaches to the diagnosis and treatment of mixed anxiety-depressive disorders in primary health care
The relevance of this work is due to the wide prevalence of mixed anxiety-depressive disorders among general medical practice patients. At the present stage of development of the psychiatric service in the Republic of Kazakhstan, a new concept has been developed that assumes the transfer of a number of borderline mixed anxiety-depressive disorders to the competence of PHC doctors with the need for their treatment with modern antidepressants. The purpose of this work. Development and implementation in general clinical practice of modern methods of diagnosis and treatment of mixed anxiety-depressive disorders. Material and methods. 30 patients with mixed anxiety-depressive disorders of the borderline level, who were treated on an outpatient basis (Nursultan) was examined. The study was conducted using international psychometric scales: Hospital Anxiety and Depression Score (HADS), Hamilton Anxiety and Depression Rating Scale (HDRS, HAM-A). Results and discussion. As a result of the study, it was found that among patients with mixed anxiety-depressive disorders who were treated on an outpatient basis, young people of working age from 21 to 50 years (83.3%) prevailed, in whom psychogenic anxiety-depressive disorders accounted for 60%. In the course of clinical observations, objective data were obtained indicating that when treating depressive states of mild and moderate severity with Mianserin drug on an outpatient basis, by the end of the second week of treatment, there is a fairly pronounced positive dynamics in the reduction of symptoms of depression. By the end of the second month of taking this drug (8 weeks), most patients had no symptoms of depression. Conclusions. Practical clinical observations have shown that the modern Mianserin antidepressant, possessing a wide range of clinical effects combining thymoanaleptic action proper with anti-anxiety, sedative and hypnotic effects is well tolerated by patients and can be recommended for widespread use in the treatment of mixed anxiety-depressive disorders in general medical practice. Keywords: depression, anxiety, primary health care, general medical practice, antidepressants.
- 13 December 2021
- Published by Healthcare of Kazakhstan in International Professional Journal "Medicine"
- Vol. 5-6 (215-216) , 53-62
Open AccessModern approaches to the diagnosis and treatment of mixed anxiety-depressive disorders in primary health care
The relevance of this work is due to the wide prevalence of mixed anxiety-depressive disorders among general medical practice patients. At the present stage of development of the psychiatric service in the Republic of Kazakhstan, a new concept has been developed that assumes the transfer of a number of borderline mixed anxiety-depressive disorders to the competence of PHC doctors with the need for their treatment with modern antidepressants. The purpose of this work. Development and implementation in general clinical practice of modern methods of diagnosis and treatment of mixed anxiety-depressive disorders. Material and methods. 30 patients with mixed anxiety-depressive disorders of the borderline level, who were treated on an outpatient basis (Nursultan) was examined. The study was conducted using international psychometric scales: Hospital Anxiety and Depression Score (HADS), Hamilton Anxiety and Depression Rating Scale (HDRS, HAM-A). Results and discussion. As a result of the study, it was found that among patients with mixed anxiety-depressive disorders who were treated on an outpatient basis, young people of working age from 21 to 50 years (83.3%) prevailed, in whom psychogenic anxiety-depressive disorders accounted for 60%. In the course of clinical observations, objective data were obtained indicating that when treating depressive states of mild and moderate severity with Mianserin drug on an outpatient basis, by the end of the second week of treatment, there is a fairly pronounced positive dynamics in the reduction of symptoms of depression. By the end of the second month of taking this drug (8 weeks), most patients had no symptoms of depression. Conclusions. Practical clinical observations have shown that the modern Mianserin antidepressant, possessing a wide range of clinical effects combining thymoanaleptic action proper with anti-anxiety, sedative and hypnotic effects is well tolerated by patients and can be recommended for widespread use in the treatment of mixed anxiety-depressive disorders in general medical practice. Keywords: depression, anxiety, primary health care, general medical practice, antidepressants.
- 13 January 2021
- Published by Healthcare of Kazakhstan in International Professional Journal "Medicine"
- Vol. 7-8 (217-218)
Modern clinical pharmacology approaches to negative symptom treatment in schizophrenia
Negative symptoms contribute to poor functional outcomes and quality of life for individuals with schizophrenia. Efficacy of negative symptom treatment in patients with schizophrenia are discussed by the example of a new atypical antipsychotic cariprazine (Reagila®). Discussion. Improved Receptor Profile: high affinity for D3 receptors and partial agonism for both dopamine receptor subtypes, may act as a basic mechanism for improving negative symptoms and cognitive impairment. Сonclusions. Сariprazine is the drug of choice in the treatment of adult patients both at the onset of the disease with a predominance of negative disorders, and in the chronic course of schizophrenia with positive and negative symptoms, especially in patients with a high risk of metabolic and cardiovascular disorders. Keywords: schizophrenia, negative disorders, antipsychotics, cariprazine.
- 13 January 2021
- Published by Healthcare of Kazakhstan in International Professional Journal "Medicine"
- Vol. 7-8 (217-218)
Modern clinical pharmacology approaches to negative symptom treatment in schizophrenia
Negative symptoms contribute to poor functional outcomes and quality of life for individuals with schizophrenia. Efficacy of negative symptom treatment in patients with schizophrenia are discussed by the example of a new atypical antipsychotic cariprazine (Reagila®). Discussion. Improved Receptor Profile: high affinity for D3 receptors and partial agonism for both dopamine receptor subtypes, may act as a basic mechanism for improving negative symptoms and cognitive impairment. Сonclusions. Сariprazine is the drug of choice in the treatment of adult patients both at the onset of the disease with a predominance of negative disorders, and in the chronic course of schizophrenia with positive and negative symptoms, especially in patients with a high risk of metabolic and cardiovascular disorders. Keywords: schizophrenia, negative disorders, antipsychotics, cariprazine.
- 31 August 2020
- Published by Healthcare of Kazakhstan in International Professional Journal "Medicine"
- Vol. 3-4 (213-214)
Mixed anxiety-depressive adaptation disorders in the presence of the COVID-19 epidemic
In the presence of the COVID-19 epidemic, due to quarantine measures, millions of people around the world are under the stress of infection and have to adapt to new conditions of social functioning. The high risk of developing of mixed anxiety-depressive adaptation disorders in the presence of COVID-19 quarantine measures determines the relevance of this study. Study purpose. To study the prevalence and clinical level of mixed anxiety-depressive disorders in medical personnel under the COVID-19 quarantine regime. Material and methods. 51 employees of the Republican national enterprise on the right of economic jurisdiction “Republican scientific and practical center of mental health” (RSPCMH) were examined: doctors, junior and medium-level medical personnel. The main study method is psychometric (Hospital Anxiety and Depression Score – HADS). Results and discussion. The work presents an analytical review of literature data on the problem of adaptation disorders and current international studies on mental disorders in medical workers under the COVID-19 quarantine regime. According to the results of this study, affective disorders in the form of depressive and anxiety-depressive reactions within the framework of adaptation disorders were detected in 37.3% of the medical staff of the RSPCMH. Conclusions. It was found that the higher the risk of COVID-19 infection, the more often depression is detected and in departments with a lower risk of infection, more often mixed anxiety-depressive disorders are detected. Preventive measures aimed at increasing the stress tolerance of medical workers are recommended. Key words: COVID-19, stress, adaptation disorders, anxiety, depression, stress protectors, tranquilizers.
- 31 August 2020
- Published by Healthcare of Kazakhstan in International Professional Journal "Medicine"
- Vol. 3-4 (213-214)
Mixed anxiety-depressive adaptation disorders in the presence of the COVID-19 epidemic
In the presence of the COVID-19 epidemic, due to quarantine measures, millions of people around the world are under the stress of infection and have to adapt to new conditions of social functioning. The high risk of developing of mixed anxiety-depressive adaptation disorders in the presence of COVID-19 quarantine measures determines the relevance of this study. Study purpose. To study the prevalence and clinical level of mixed anxiety-depressive disorders in medical personnel under the COVID-19 quarantine regime. Material and methods. 51 employees of the Republican national enterprise on the right of economic jurisdiction “Republican scientific and practical center of mental health” (RSPCMH) were examined: doctors, junior and medium-level medical personnel. The main study method is psychometric (Hospital Anxiety and Depression Score – HADS). Results and discussion. The work presents an analytical review of literature data on the problem of adaptation disorders and current international studies on mental disorders in medical workers under the COVID-19 quarantine regime. According to the results of this study, affective disorders in the form of depressive and anxiety-depressive reactions within the framework of adaptation disorders were detected in 37.3% of the medical staff of the RSPCMH. Conclusions. It was found that the higher the risk of COVID-19 infection, the more often depression is detected and in departments with a lower risk of infection, more often mixed anxiety-depressive disorders are detected. Preventive measures aimed at increasing the stress tolerance of medical workers are recommended. Key words: COVID-19, stress, adaptation disorders, anxiety, depression, stress protectors, tranquilizers.